The purpose of this paper is to evaluate factors affecting the outcome of cholangitis after PTBD in jaundiced cancer patients. Twenty nine patients with neoplastic jaundice (male/female ratio 13/16, median age 55 years) with full clinical data, were treated by PTBD and developed cholangitis at a median of 9 days later. Four patients (14%) died of biliary sepsis a median of one month after PTBD while the other 25 survived a median of 6 months, with one week median duration of cholangitis. The probability of the cholangitis resolving was analyzed by time to resolution and it was found that 50% and 100% of the recoveries occurred 5 and 9 months respectively from the onset of the complication.
necessary by Percutaneous Transhepatic Biliary Drainage (PTBD); this will reduce bilirubin preoperatively (5) with an improvement in hepatic regeneration and Kupffer cell response, and it provides definitive treatment if there is no surgical option. In the period from 1985 to 1989, 306 PTBDs were performed at the Istituto Nazionale Tumori of Milan.
We define cholangitis or recurrent cholangitis as a single or recurrent septic event with spiking fever exceeding 38.5 C, weakness sometimes accompanied by prostration, chills, hypotension and no sign of sepsis elsewhere.
The purpose of this paper is to define the mortality rate of cholangitis and the prognostic factors associated with a positive outcome. The incidence of cholangitis was 17 .5% in cancer patients and 10.5% in non cancer patients with a total of 46 occurrences, six had inadequate clinical records seven had non neoplastic strictures and four had had major liver surgery so that their clinical septic course could be confused with postoperative subphrenic abscess, leaving only 29 occurrences in 28 patients for the present study.
In present series of 29 cancer patients (13 males and 16 females, median age 55 years, range 32 to 73 years), all had a histologically proven neoplastic stricture due to: primary liver cancer (10) or liver metastasis from colorectal cancer (9) , gastric cancer (4), breast cancer (1) or gynecological malignancy (1); 4 subjects had pancreatic cancer and two of these had synchronous liver metastases. PTBD was the only procedure used to treat these patients who were poor candidates for other forms of palliation.
Data defining the patients' general condition, biochemistry, aetiology of jaundice and characteristics of the stricture are given in Table 1. Table 2 gives information about PTBD itself as well as procedures undertaken to improve bile flow through the catheter. Eighteen patients had an 8F and 11 had a 10F catheter. At the onset of cholangitis, it was externally opened in 7 patients and closed in 22, its tip passing through and below the stricture. according to the ZUBROD-WHO scale At the onset of cholangitis median body temperature was 39 C (range 38.5--40) and the median white cell count was 18100/mL (7800-35000); bile was cultured and antibiotic sensitivities determined. Therapeutic antibiotics were given for a median of 13 days (range 5-40).
A third generation cephalosporin was administered to nineteen subjects; the other ten were given specific antibiotics according to sensitivity tests. Twenty-two patients were given intravenous antibiotics and seven had the drug injected into the biliary tree through the catheter. Drainage catheters were changed once in 15 patients and more than once in 14 (median 3, range 2-11).
Follow-up time was a median of four months (range 1-27 months) from PTBD until death.
The duration of cholangitis was defined as the number of days from onset to its resolution indicated by an absence of clinical signs, no fever and a normal white cell count.
STATISTICAL EVALUATION
Each variable had two possibilities (Table 2) and the proportion of patients who recovered from cholangitis was computed for each of the two categories. Statistical significance of the difference between the two proportions obtained was tested by Chi-square after arcsein transformation of the proportions6.
Statistical significance at the .05 level can only be achieved by having at least five patients in the smallest group. Thus all variables with less than five subjects in one of the two groups were not evaluated.
Patients who recovered from cholangitis were further evaluated to define a possible role for each of the variables in producing a shorter clinical course.
RESULTS
Twenty five patients (86%) had a single episode of acute cholangitis; of these, twenty one (72%) recovered and 4 (14%) died of sepsis related to cholangitis lasting a median of one month. Four subjects suffered recurrences (14%).
Cholangitis occurred a median of 9 days from PTBD (range 1 day 7 months), and lasted a median of 7 days (1-20 days). Sixteen patients died of progressive malignancy a median of 6 months from PTBD and 2 died of other causes after 7 and 8 months respectively; seven subjects are alive a median of 8 months after PTBD. Details concerning outcome and clinical course of cholangitis are reported in Table   3 . Thirty-day mortality was 7% (2 patients, one of which died of neoplastic disease without sepsis).
Out of the large number of variables considered (Tables 1 and 2) , only a few prognostic factors proved statistically related to a better prognosis in cholangitis: a stricture below the confluence of the two main ducts, a large catheter (10F or more in diameter) and a patient response suggested by an increase in body temperature to greater than 39 C (Table 4 ).
All previously reported variables were also analyzed for correlation with the duration of cholangitis but none was found.
Bacteriological examination of the bile sample was performed in 13 patients at the onset of cholangitis: in one case Klebsiella was cultured alone, and in two cases only Pseudomonas species were grown; most frequently (70% of the cultured cases) the presence of enteric bacteria such as E. coli leakage, bleeding, electrolyte and nutritional deficiencies, but sepsis related problems stand out. Cholangitis is a frequent complication, its prevalence ranging from 14.5% (2) to almost 50% (9) (10) (11) and it is more frequently observed in patients with malignancies (54%) than in those with benign disease (22%) 12 It is well documented by Thompson 13 that neoplastic jaundice is more prone to cause recurrent cholangitis and more likely to be fatal than is the case with stones.
The availability of a large number of effective antibiotic drugs and biliary decompression makes the difference between the present mortality rate for cholangitis ranging from 9 to 40% (9, (13) (14) (15) (16) We should consider PTBD as an effective procedure in most jaundiced neoplastic patients because of the increased cure rate of cholangitis and the low procedurerelated mortality rate. This is also supported by a satisfactory overall median survival period of 6 months after PTBD.
